Cardiovascular effects of pyrogallol and 4-tropoloneacetamide.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001949:Bretylium Compounds / Q000494:pharmacology; D003516:Cycloparaffins / Q000494:pharmacology*; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D007022:Hypotension / Q000139:chemically induced; D007659:Ketones / Q000494:pharmacology*; D008297:Male; D008680:Metaraminol / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014166:Transferases / Q000037:antagonists & inhibitors; D014439:Tyramine / Q000494:pharmacology
D001949:Bretylium Compounds; D003516:Cycloparaffins; D007659:Ketones; D011748:Pyrogallol; D008680:Metaraminol; D012110:Reserpine; D014166:Transferases; D014439:Tyramine; D006145:Guanethidine